By blocking SCD, we were able to restore NK cell killing of NGFR-overexpressing melanoma cells in vivo (Fig. 6G), as reflected by a notable loss of MF438-treated NGFR-overexpressing cells in mice engrafted with human NK cells (Fig. 6, H and I). Here, SCD is linked to melanoma.